| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,625,765 | 1,448,819 | 2,898,617 | 2,471,798 | | Cost of Revenue | 1,849,412 | 2,135,429 | 1,605,124 | 8,271,543 | | | Gross Profit | (223,647) | (686,610) | 1,293,493 | (5,799,745) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
|
-
| 1,665,006 | (4,737,734) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (223,647) | (686,610) | (371,513) | (1,062,011) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,446 | (6,446) | 107,702 | (88,029) | | Earnings Before Interest And Taxes | (215,227) | (693,056) | (453,833) | (1,093,913) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (215,227) | (693,056) | (453,833) | (1,093,913) | | Income Tax Expense | (56,810) | 3,088 | 439,490 | (306,042) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (158,417) | (696,144) | (893,323) | (787,871) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 18,662 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (158,417) | (696,144) | (874,661) | (787,871) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($158,417) | ($696,144) | ($874,661) | ($787,871) |
|
0.29% Nasdaq 
0.14%
Income Statement
